Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 255,323 | 252,901 | 254,219 | 258,514 | 240,449 |
| Cost of Goods | 42,654 | 46,321 | 44,979 | 45,970 | 42,920 |
| Gross Profit | 212,669 | 206,580 | 209,240 | 212,544 | 197,529 |
| Operating Expenses | 180,436 | 175,065 | 174,386 | 176,065 | 164,945 |
| Operating Income | 32,887 | 31,836 | 35,833 | 37,449 | 33,504 |
| Interest Expense | 10 | 20 | 46 | 176 | 202 |
| Other Income | 492 | -41 | 314 | 395 | -294 |
| Pre-tax Income | 33,369 | 31,775 | 36,101 | 37,668 | 33,008 |
| Income Tax | 12,011 | 9,893 | 6,003 | 11,906 | 10,709 |
| Net Income Continuous | 21,358 | 21,882 | 30,098 | 25,762 | 22,299 |
| Net Income | $21,358 | $21,882 | $30,098 | $25,762 | $22,299 |
| EPS Basic Total Ops | 0.87 | 0.90 | 1.24 | 1.08 | 0.92 |
| EPS Basic Continuous Ops | 0.87 | 0.89 | 1.24 | 1.08 | 0.92 |
| EPS Diluted Total Ops | 0.86 | 0.87 | 1.20 | 1.03 | 0.89 |
| EPS Diluted Continuous Ops | 0.86 | 0.87 | 1.20 | 1.03 | 0.89 |
| EBITDA(a) | $36,353 | $35,388 | $39,009 | $40,683 | $37,024 |